Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Henchcliffe

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Neurological Disorders|November 2, 2016
Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosisHarini Sarva, Claire Henchcliffe
CNS Drugs|May 31, 2020
Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's DiseaseClaire Henchcliffe, Harini Sarva
Expert Review of Clinical Pharmacology|January 18, 2018
Valbenazine as the first and only approved treatment for adults with tardive dyskinesiaHarini Sarva, Claire Henchcliffe
Neuropsychiatric Disease and Treatment|August 30, 2008
Rasagiline in treatment of Parkinson's diseaseLakshmi Nayak, Claire Henchcliffe
Expert Opinion on Pharmacotherapy|June 27, 2002
Entacapone in the management of Parkinson's diseaseClaire Henchcliffe, Cheryl Waters
Neural Regeneration Research|February 1, 2026
Advances and unmet needs in fluid and tissue biomarkers in Parkinson's diseaseRavi Rajmohan, Claire Henchcliffe
Current Opinion in Neurology|July 10, 2012
Biomarkers in Parkinson's disease: an updateAlexander Shtilbans, Claire Henchcliffe
Journal of Parkinson'S Disease|December 26, 2018
Repairing the Brain: Cell Replacement Using Stem Cell-Based TechnologiesClaire Henchcliffe, Malin Parmar
CNS Drugs|July 10, 2025
Investigational Gene Therapies for Parkinson's DiseaseNicolas Phielipp, Claire Henchcliffe
Drugs & Aging|August 5, 2011
Disease modification in Parkinson's diseaseClaire Henchcliffe, W Lawrence Severt
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Neurological Disorders|November 2, 2016
Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosisHarini Sarva, Claire Henchcliffe
CNS Drugs|May 31, 2020
Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's DiseaseClaire Henchcliffe, Harini Sarva
Expert Review of Clinical Pharmacology|January 18, 2018
Valbenazine as the first and only approved treatment for adults with tardive dyskinesiaHarini Sarva, Claire Henchcliffe
Neuropsychiatric Disease and Treatment|August 30, 2008
Rasagiline in treatment of Parkinson's diseaseLakshmi Nayak, Claire Henchcliffe
Expert Opinion on Pharmacotherapy|June 27, 2002
Entacapone in the management of Parkinson's diseaseClaire Henchcliffe, Cheryl Waters
Neural Regeneration Research|February 1, 2026
Advances and unmet needs in fluid and tissue biomarkers in Parkinson's diseaseRavi Rajmohan, Claire Henchcliffe
Current Opinion in Neurology|July 10, 2012
Biomarkers in Parkinson's disease: an updateAlexander Shtilbans, Claire Henchcliffe
Journal of Parkinson'S Disease|December 26, 2018
Repairing the Brain: Cell Replacement Using Stem Cell-Based TechnologiesClaire Henchcliffe, Malin Parmar
CNS Drugs|July 10, 2025
Investigational Gene Therapies for Parkinson's DiseaseNicolas Phielipp, Claire Henchcliffe
Drugs & Aging|August 5, 2011
Disease modification in Parkinson's diseaseClaire Henchcliffe, W Lawrence Severt
Pageof 8